欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/1132/001
药品名称Melphalan Hikma 50 mg powder and solvent for solution for injection/infusion
活性成分
    • Melphalan hydrochloride 50.0 mg
剂型Powder and solvent for solution for injection/infusion
上市许可持有人Hikma Farmacêutica (Portugal) S.A. Estrada Rio Da Mo 8, 8-A e 8-B, Fervença 2705-906 Terrugem Snt, Portugal Portugal
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Germany (DE)
      Melphalan Hikma 50 mg Pulver und Lösungsmittel zur Herstellung einer Injektions-/ Infusionslösung
    • Belgium (BE)
    • Netherlands (NL)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • United Kingdom (Northern Ireland) (XI)
许可日期2023/02/15
最近更新日期2025/01/13
药物ATC编码
    • L01AA03 melphalan
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase